Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003488338 | SCV004238788 | likely pathogenic | not provided | 2022-01-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003987318 | SCV004805104 | likely pathogenic | Gilbert syndrome | 2024-03-17 | criteria provided, single submitter | research | |
OMIM | RCV000013076 | SCV000033322 | pathogenic | Crigler-Najjar syndrome type 1 | 2002-05-01 | no assertion criteria provided | literature only | |
Neonatal Research Center, |
RCV000013076 | SCV001653517 | pathogenic | Crigler-Najjar syndrome type 1 | 2021-03-10 | no assertion criteria provided | research | We identified an insertion mutation (UGT1A1*28) in the promoter and a missense mutation (c.1070A>G; p.Gln357Arg) in the homozygous state in exon 3 of the UGT1A1 gene in a 4.5 months old boy. We studied the family history of the patient to evaluate the penetration of mutations in the family. The patients are the offspring of consanguineous marriage. Proband had two affected cousins that both of them died due to CNS-1 with similar mutations. They were treated using liver transplantation. Based on predictors, the impact of the c.1070A>G mutation on protein structure is deleterious, damaging, and likely disease-causing. The p.Gln357Arg mutation previously established as a pathogenic variant and well-established in vitro functional studies supportive of a damaging effect on the UGT1A1 gene product. The p.Gln357Arg mutation cosegregation with CNS-1 disease in multiple affected family members in a gene definitively known to cause the disease, and patient’s phenotype is highly specific for a disease with a single genetic etiology. |